课题基金 / 基金详情

COVID-19 Variant Supplement - Understand the high pathogenicity and zoonotic transmission of the COVID-19 virus: evasion of host innate immune responses

COVID-19 Variant Supplement - Understand the high pathogenicity and zoonotic transmission of the COVID-19 virus: evasion of host innate immune responses
COVID-19 变异补充剂 - 了解 COVID-19 病毒的高致病性和人畜共患传播：逃避宿主先天免疫反应
批准号：
442863
负责人：
Liang Chen
金额：
$3.64万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-02-01 至 2022-02-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=442863&lang=en
关键词：
Covid-19 Innate Immune Response Interferon Sars-Cov Viral Pathogenicity Zoonotic Transmission

项目摘要

项目成果

Liang Chen的其他基金

相似基金

相关文献

中文摘要
翻译
冠状病毒对人类来说并不陌生。人类冠状病毒OC 43和229 E早在20世纪60年代就被发现。这两种病毒都会引起普通感冒，一种轻微的上呼吸道感染。然而，2002年，当SARS爆发时，情况开始发生变化。
英文摘要
Coronaviruses are not new to humans. The human coronaviruses OC43 and 229E were discovered as early as in the 1960s. Both viruses cause common cold, a mild infection of our upper respiratory tract. However, the story started to change in 2002 when SARS br
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigate the immune modulation function of SARS-CoV-2 accessory protein ORF8
Understand the high pathogenicity and zoonotic transmission of the COVID-19 virus: evasion of host innate immune responses
Sex as a Biological Variable Supplement - Understand the high pathogenicity and zoonotic transmission of the COVID-19 virus: evasion of host innate immune responses
Understanding the NMD regulatory path from genetic variation to phenotypes
海外基金